Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Controlled Study of the Efficacy of Botulinum Toxin A (Botox) for the Treatment of Social Anxiety Disorder (SAD)

NCT03078270 is registered in ClinicalTrials.gov with Daniel Lieberman as lead sponsor.

NCT NCT03078270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03078270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Controlled Study of the Efficacy of Botulinum Toxin A (Botox) for the Treatment of Social Anxiety Disorder (SAD)
Lead sponsor
Daniel Lieberman
Phase
Phase 4
Overall status
Terminated
Start date
February 1, 2017
Completion date
September 12, 2017
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, anxiety disorder social